Karl Maria Schumacher

Statistics

Publications

Citations

592

H-Index

Active since

2008

Affiliations

Institute of Bioengineering and Nanotechnology(Current)

Merck KGaA, Darmstadt (Germany)

National Cancer Centre Singapore

Institut Català d'Oncologia

Karl Maria Schumacher is an author at Institute of Bioengineering and Nanotechnology specializing in biomaterials, oncology, and non-small cell lung cancer therapy.

Publications per year

2008–2021

Publications

Human embryonic stem cells differentiate into functional renal proximal tubular–like cells

Karthikeyan Narayanan, Karl Maria Schumacher, Farah Tasnim et al. · Kidney International · 2013 · 151 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +14

Hydrodynamic spinning of hydrogel fibers

Min Hu, Rensheng Deng, Karl Maria Schumacher et al. · Biomaterials · 2009 · 140 citations

Natural Sciences, Materials Engineering, Materials Science +13

Cell immobilization in gelatin–hydroxyphenylpropionic acid hydrogel fibers

Min Hu, Motoichi Kurisawa, Rensheng Deng et al. · Biomaterials · 2009 · 130 citations

Engineering, Bioengineering, Biomedical Engineering +12

INSIGHT 2: a Phase II Study of Tepotinib Plus Osimertinib in <i>MET</i> -Amplified NSCLC and First-Line Osimertinib Resistance

Egbert F. Smit, Christophe Dooms, Jo Raskin et al. · Future Oncology · 2021 · 52 citations · Full text

Medicine, Oncology, Pharmacology +16

Preliminary results from a phase Ib/II, open-label, dose-escalation study of the oral BRAF inhibitor LGX818 in combination with the oral MEK1/2 inhibitor MEK162 in <i>BRAF</i> V600-dependent advanced solid tumors.

Richard Kefford, Wilson H. Miller, Daniel Shao-Weng Tan et al. · Journal of Clinical Oncology · 2013 · 43 citations

Pharmacy, Oncology, Pharmacology +15

1–5 of 9